Research Findings and Grantee Highlights in 2021
CPRIT’s $2.86 billion investment in 1,679 of the best ideas in cancer research, product development, and prevention has enhanced Texas’ role in the global fight against cancer. A snapshot of some notable research findings reported in fiscal
year 2021, as well as other important milestones, awards and prestigious appointments, and prevention outreach, are shown below.
- CPRIT core director Abbey Berenson, M.D., Ph.D., was named as a 2021 Immunization Champion by the American College of Obstetricians and Gynecologists (ACOG) in August 2021. As the director of the Center for Interdisciplinary Research in Women’s
Health at The University of Texas Medical Branch at Galveston, Dr. Berenson has led HPV vaccination projects across Texas with the help of more than $15 million in CPRIT grant funding. Dr. Berenson credits her award to her outstanding work she
has conducted through CPRIT’s Prevention Program.
- The National Cancer Institute’s official blog Cancer Currents features
Abbey Berenson, M.D., Ph.D., professor of obstetrics and gynecology at The University of Texas Medical Branch at Galveston, in an October 14, 2020 article, which examines a study that proves the HPV vaccine dramatically reduces
incidents of cervical cancer in widely vaccinated populations. This study of nearly 1.7 million women provides an incredibly important message, Dr. Berenson explained, because it proves that women who receive the vaccine before age 17 are better
protected against cervical cancer. Dr. Berenson is the program director for eight CPRIT-funded HPV vaccination projects. With CPRIT’s support, Dr. Berenson and her colleagues are increasing Texans’ access to cancer prevention services
and information. In February of 2019, Dr. Berenson received a $1.4 million CPRIT Academic Research award (RP190022) to lead a trial that compares the effectiveness of two doses versus three doses of the HPV vaccine in people 15–26 years
CPRIT 2021 Annual Report Highlights